Vorasidenib Placebo Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

European Organisation for Research and Treatment of Cancer - EORTC1

Indications

IDH-mutant Grade 2 or 3 Astrocytoma1
Cancer1

Other1 trial

Vorasidenib Maintenance for IDH Mutant Astrocytoma

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.